Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells

Currently, many types of cell-based therapeutic products (CTPs) derived from pluripotent stem cells (PSCs) are being developed in a lot of countries, some of which are in clinical trial stages. CTPs are classified differently in different countries and regions. The evaluation of their efficacy, safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Takamasa, Yasuda, Satoshi, Umezawa, Akihiro, Sato, Yoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444560/
https://www.ncbi.nlm.nih.gov/pubmed/37557074
http://dx.doi.org/10.1016/j.stemcr.2023.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444560/
https://www.ncbi.nlm.nih.gov/pubmed/37557074
http://dx.doi.org/10.1016/j.stemcr.2023.05.003

Ejemplares similares